A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol

A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol

Abstract Background Since the development of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy (IMRT), no prospective study has investigated whether concurrent chemoradiotherapy (SIB-IMRT with 60 Gy) remains superior to radiotherapy (SIB-IMRT) alone for unresectable esoph...

Full description

Bibliographic Details
Main Authors: Lin-rui Gao, Xin Wang, Weiming Han, Wei Deng, Chen Li, Xiaomin Wang, Yidian Zhao, Wenjie Ni, Xiao Chang, Zongmei Zhou, Lei Deng, Wenqing Wang, Wenyang Liu, Jun Liang, Tao Zhang, Nan Bi, Jianyang Wang, Yirui Zhai, Qinfu Feng, Jima Lv, Ling Li, Zefen Xiao
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Cancer
Subjects:
Esophageal cancer
Concurrent chemoradiotherapy
Definitive chemoradiotherapy/radiotherapy
Consolidated chemotherapy
Simultaneous integrated boost
Intensity-modulated radiotherapy
Online Access:http://link.springer.com/article/10.1186/s12885-020-07387-y

Internet

http://link.springer.com/article/10.1186/s12885-020-07387-y

Similar Items